Zydus Lifesciences announced today that it has received approval from WHO International Non-proprietary Names (INN) for Usnoflast as the recommended name for ZYIL1. The INN system aims to provide healthcare professionals with a unique and universal designated name for each pharmaceutical substance.
| Subscribe To Our Free Newsletter |
